Immunic Inc (NASDAQ:IMUX), a late-stage biotechnology company developing oral treatments for neurological and gastrointestinal diseases, will participate in two investor conferences this month.
Chief executive Daniel Vitt and president Jason Tardio will take part in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami on 11 March, with one-on-one investor meetings also scheduled across the event, which runs from 8 to 11 March.
The pair will also appear at the Stifel 2026 Virtual CNS Forum on 18 March, participating in a fireside chat at 4pm Eastern time, alongside further one-on-one meetings.
Webcasts of both presentations will be available through the investor relations section of Immunic's website.
Investors wishing to schedule meetings can contact the respective conference representatives or the company's head of investor relations, Jessica Breu (jessica.breu@imux.com).